- Home
- RNA vs TNET Comparison
RNA vs TNET Comparison
Compare RNA & TNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNA
- TNET
- Stock Information
- Founded
- RNA 2012
- TNET 1988
- Country
- RNA United States
- TNET United States
- Employees
- RNA N/A
- TNET N/A
- Industry
- RNA Biotechnology: Pharmaceutical Preparations
- TNET Business Services
- Sector
- RNA Health Care
- TNET Consumer Discretionary
- Exchange
- RNA Nasdaq
- TNET Nasdaq
- Market Cap
- RNA 4.0B
- TNET 3.0B
- IPO Year
- RNA 2020
- TNET 2014
- Fundamental
- Price
- RNA $69.82
- TNET $55.78
- Analyst Decision
- RNA Buy
- TNET Hold
- Analyst Count
- RNA 20
- TNET 4
- Target Price
- RNA $69.26
- TNET $77.33
- AVG Volume (30 Days)
- RNA 9.8M
- TNET 500.5K
- Earning Date
- RNA 11-07-2025
- TNET 10-29-2025
- Dividend Yield
- RNA N/A
- TNET 1.97%
- EPS Growth
- RNA N/A
- TNET N/A
- EPS
- RNA N/A
- TNET 2.65
- Revenue
- RNA $10,729,000.00
- TNET $4,971,000,000.00
- Revenue This Year
- RNA N/A
- TNET $2.49
- Revenue Next Year
- RNA $108.97
- TNET $3.17
- P/E Ratio
- RNA N/A
- TNET $21.06
- Revenue Growth
- RNA 1.23
- TNET N/A
- 52 Week Low
- RNA $21.51
- TNET $54.61
- 52 Week High
- RNA $70.51
- TNET $98.51
- Technical
- Relative Strength Index (RSI)
- RNA 79.30
- TNET 30.81
- Support Level
- RNA $69.50
- TNET $54.61
- Resistance Level
- RNA $69.86
- TNET $65.13
- Average True Range (ATR)
- RNA 0.88
- TNET 2.47
- MACD
- RNA 0.81
- TNET -0.46
- Stochastic Oscillator
- RNA 91.19
- TNET 6.32
About RNA Avidity Biosciences Inc.
Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.
About TNET TriNet Group Inc.
Trinet Group Inc outsourced payroll and human capital management solutions for small and midsize businesses via a professional employer organization model. Under the PEO model, TriNet enters a co-employment arrangement and acts as the employer of record for administrative and regulatory purposes for clients' employees, known as worksite employees. Clients leverage the scale and expertise of TriNet to access competitive employee benefits, share employment risk liability, access compliance support, and outsource mission-critical day-to-day HR functions such as payroll and tax administration. Following the acquisition of Zenefits and Clarus R+D in 2022, TriNet derives the minority of its revenue from self-service HCM software and R&D tax credit services.